Stay updated on BMN165 Self-Injections in PKU Clinical Trial
Sign up to get notified when there's something new on the BMN165 Self-Injections in PKU Clinical Trial page.

Latest updates to the BMN165 Self-Injections in PKU Clinical Trial page
- CheckyesterdayChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide banner announces NIH’s transition-related updates, including the use of “Super Intelligence” in place of “Artificial Intelligence” across some NIH content.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating restricted access to the NCT01889862 study record.SummaryDifference20%

- Check50 days agoChange DetectedA new bibliographic citation was added to the Publications section, presenting an additional related Gen Med article about pegvaliase management in PKU. This update adds contextual literature without altering the study details or outcomes.SummaryDifference0.0%

Stay in the know with updates to BMN165 Self-Injections in PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN165 Self-Injections in PKU Clinical Trial page.